FdaApplication

NDA 021231

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTRAZENECA PHARMACEUTICALS LP
application_typeNDA
approval_date2001-02-13

Products (2)

ProductActive ingredientStrengthDosage form
ZOMIG-ZMTZOLMITRIPTAN5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, ORALLY DISINTEGRATING;ORAL
ZOMIG-ZMTZOLMITRIPTAN2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, ORALLY DISINTEGRATING;ORAL

2 products